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By utilizing speciﬁc frequencies in the range of 6-30Hz based on tissue
type and grade of osteoarthritis this stimulus is recreated by SPMF therapy
leading to cartilage regeneration.
This recreated peizoelectric stimuli, is known to enhance mitosis and
cell regeneration by normalizing the abberant electromagnetic ﬁelds of
microtubules of the centrioles
Methods: 195 patients with bilateral osteoarthritis (OA) of knees were
assessed by internationally recognized Knee Society clinical rating system;
the scores computed prior to treatment, after 21 days of therapy, at 3 and
9 months. In addition, MRI of the treated knees was done using standard
protocol, before treatment, at three and nine months after treatment, to
measure objective changes in cartilage thickness.
Results: This non-randomized, phase II study showed statistically highly
signiﬁcant improvement in pain scores, total knee scores, total functional
scores and the range of motion, immediately after the treatment vis-à-vis
pre-treatment values, and this improvement persisted when re-evaluated
at three and nine months. There was also a signiﬁcant increase in cartilage
thickness at three months and nine months from 0.64mm (±0.02) baseline
to 0.88 mm (±0.07) in left knee, and 0.65mm (±0.02) to 0.89mm (±0.05)
in the right knee joint (p<0.001) at 3 months and to 1.26mm (±0.02mm)
in the left knee and 1.23mm (±0.03mm) in the right knee at the end of 9
months.
Conclusions: Therapeutic exposure to SPMF therapy is effective in ame-
liorating the signs and symptoms of OA, and inducing regeneration of
chondrocytes as evidenced by increase in cartilage thickness. SPMF therapy
is an effective treatment modality for osteoarthritis.
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EXPANSION AND CHONDROGENIC DIFFERENTIATION OF HUMAN BONE
MARROW-DERIVED MESENCHYMAL STEM CELLS FOLLOWING
RAAV-MEDIATED GENE TRANSFER AND OVEREXPRESSION OF HUMAN
FGF-2
H. Madry, D. Kohn, M. Cucchiarini
Inst. for Experimental Orthopaedics, Homburg/Saar, Germany
Purpose: Articular cartilage lesions are an important problem in or-
thopaedic surgery. The use of progenitor cells such as bone marrow-derived
mesenchymal stem cells (MSCs), as platforms to deliver candidate genes
in a suitable conformation is an attractive approach to enhance cartilage
repair. Here, we tested the ability of rAAV vectors to overexpress FGF-2
that promotes the expansion and differentiation of human MSCs in a
three-dimensional environment.
Methods: rAAV were packaged, puriﬁed, and titrated as previously de-
scribed. All transgene cassettes were controlled by the CMV-IE pro-
moter/enhancer: E. coli beta-galactosidase (rAAV-lacZ), Red Fluorescent
Protein (rAAV-RFP), Fireﬂy luciferase (rAAV-luc), and a human basic ﬁbrob-
last growth factor (hFGF-2) cDNA (rAAV-hFGF-2). Bone marrow aspirates
were obtained from the iliac crest of donors. Aspirates were layered onto
Histopaque-1077 density gradient and the nucleated cell fraction was
collected and resuspended in hMSC culture medium containing stimulatory
supplements (StemCell Technologies Inc.). Cells were transduced with rAAV
for up to 21 days in monolayer or in aggregate cultures (2×105 cells). Ag-
gregates were kept in DMEM high glucose, ITS+ Premix, pyruvate, ascorbate
2-phosphate, dexamethasone, and TGF-β. Transgene expression was deter-
mined by X-Gal staining, live ﬂuorescence, luciferase assay, FGF-2 ELISA,
and by immunocyto- and immunohistochemistry. Paraﬃn-embedded sec-
tions of aggregates (5 μm) were stained with toluidine blue and alizarin
red. Indirect immunostaining was also performed to detect type-II and
type-X collagen, Runx-2, and Sox9. The DNA contents were monitored by
ﬂuorimetric assay, the proteoglycan contents by binding to DMMB, and
the type-II collagen contents by ELISA. Morphometric measurements were
performed at 3 standardized sites by image analysis. Each condition was
performed in triplicate in 2 independent experiments. Data are expressed
as mean ± SD. The t-test was employed with P<0.05 considered statistically
signiﬁcant.
Results: Sustained, dose-dependent transgene expression was observed in
monolayer cultures of hMSCs, with FGF-2 levels being from 350.2±2.5 to
41.1±1.2 pg/ml/24 h over time in rAAV-hFGF-2-transduced cells vis a vis
rAAV-lacZ (< 0.01 pg/ml/24 h). Luciferase activity was of 16.3±0.6 RLU/mg
total proteins after 21 days in rAAV-luc-transduced cells compared with
rAAV-lacZ (0.2±0.1 RLU/mg total proteins). Eﬃcient, sustained transgene
expression was also seen in aggregates (Fig. 1), with FGF-2 levels from
375.1±1.6 to 136.1±1.4 pg/ml/24 h over time in rAAV-hFGF-2 aggregates
Figure 1. Transgene expression in hMSCs aggregates (day 21).
Figure 2. Toluidine blue staining and detection of type-II collagen in hMSCs aggregates
(day 21).
vis a vis rAAV-lacZ (1.51±0.4 pg/ml/24 h). Chondrogenic differentiation of
cells was observed after 21 days in all types of aggregates (Fig. 2). Sox9
immunoreactivity was visible, whereas that for type-X collagen and Runx-2
and alizarin red staining were less intense. The diameters (856±30 versus
538±36 μm), DNA contents (1.039±0.005 versus 0.942±0.009 ng/mg total
proteins), and cell numbers (862±14 versus 435±12 cells/mm2) of the FGF-
2 aggregates were signiﬁcantly higher than those of the lacZ aggregates
(1.6-fold, 1.2-fold, and 1.9-fold, respectively; always P<0.001). In con-
trast, there was no difference in the proteoglycan contents (0.80±0.10 vs.
0.77±0.05 ng/mg total proteins) and type-II collagen contents (0.023±0.005
vs. 0.020±0.010 ng/mg total proteins) between both types of aggregates
(always P=1).
Conclusions: The data show that FGF-2 can be overexpressed in MSCs
via rAAV, promoting expansion and differentiation in a three-dimensional
environment, suggesting that gene modiﬁcation of MSCs via rAAV may ﬁna
application to treat articular cartilage lesions.
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CUMULATIVE EFFECT OF MECHANICAL STIMULUS ON CHONDROGENESIS
OF HYMAN MESENCHYMAL STEM CELL IN SCAFFOLDS USED FOR
CARTILAGE REPAIR
Z. Luo, M. Pullan, J. Hudson, R. Shore, B. Seedhom
Univ. of Leeds, Leeds, United Kingdom
Purpose: The aim of the study is to better understand the induction and
remodelling of cartilage-like tissue in non-woven ﬁlamentous scaffolds
intended for cartilage repair. The two objectives were to: 1) investigate the
effect of cumulative mechanical stimulus on cell proliferation, morphology
and metabolic activity in human bone marrow mesenchymal stem cells
(BMMSCs). These cells were seeded onto non-woven pads of biomaterial
and pulsatile hydrostatic pressure (PHP) applied incrementally over a 10
week period in a manner that simulates the loading conditions occurring at
a cartilage repair site after the implantation of scaffolds for cartilage repair,
and 2) thereby obtain an optimal post-operative rehabilitation regime
following joint implant surgery.
Methods: Human BMMSCs (Lonza) from 3 donors were seeded onto
226 plasma treated polyester scaffolds (PTPS) at 2.5×105 cells/scaffold
and divided into 2 groups; group one being subjected to PHP, group
two remained unloaded and acted as control. In group one, cell-seeded
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scaffolds were placed individually in a custom made multiple chamber
bioreactor which allowed application of physiologically relevant PHP on
multiple independent test specimens simultaneously. PHP was applied
incrementally, starting from 0.1 MPa to 5 MPa. Each load was applied to
the cell-scaffold construct for 30 minutes per day, 5 days per week. The
loading regime changed incrementally every two weeks for 10 weeks. DNA
and GAG production was evaluated at the end of each loading regime. Cell
viability was assessed by using a live-dead cell staining kit and measured
via confocal microscope. Selected samples were examined by scanning
electronic microscopy (SEM). Mechanical properties of the constructs were
determined by measuring the compressive modulus using an unconﬁned
uniaxial compression test at 8 and 10 weeks.
Results: Cell survival was between 70%-95% over 10 weeks culture period.
The results showed that GAG production increased with time although
variation among the three donors was observed (Fig. 1). There was a trend
toward higher GAGs synthesis in the PHP group for two donors when
measured by total GAG production per microgram DNA (Fig. 2). Taking
together both cumulated GAG content and synthesis from 2 donors, GAGs
synthesis was signiﬁcant greater at 2 and 4 weeks in the PHP group than
the control group (p<0.05). SEM shown that there were higher densities of
tissue formed in PHP group than the controls (Fig. 3). Similar mechanical
properties were observed in both groups.
Figure 3
Discussion and Conclusions: GAG production increase with time when
PHP was applied incrementally over 10 week period. There appears to
be signiﬁcant enhancement of tissue induction and chondrogenesis within
synthetic scaffolds when engineered tissue is subject to PHP at the early
stage of the culture. Because the neo-tissue is so fragile and cannot endure
high mechanical load, the lower load should be preferred. It is believed
this experimental model is more representative of conditions experienced
in vivo by scaffold implants over the early weeks post surgery. The main
outcome of this study will inform surgery on the optimal post-operative
rehabilitation regime. However, PHP did not inﬂuence the mechanical
properties of engineered tissue over the experimental period. Additional
studies need to be performed to optimise the time of application of PHP
and other associated mechanical stimuli.
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CHARACTERIZATION OF STEM CELL SURVIVALWITHIN AN IN SITU
POLYMERIZING HYALURONAN HYDROGEL
L. Song1, M. Long1, S. Coyle1, D. Gravett2, P. He2
1Stryker Orthopaedics, Mahwah, NJ; 2Carbylan Biosurgery, Palo Alto, CA
Purpose: Mesenchymal stem cells (MSCs) are considered one of the
promising biologics to treat joint diseases. The successful clinical usage of
these cells lies in the eﬃcacy of delivering cells to the location targeted
for treatment and maintaining these cells in a viable and functional form
after implantation. Among all the solid and viscous carriers investigated
so far, hydrogels have the advantage of delivering and releasing cells in
a controlled manner. This study investigates cellular response of human
MSCs to a novel, in situ crosslinking, hyaluronan (HyA) based hydrogel.
It was hypothesized the HyA hydrogel would support cell survival for a
period of time at high cell densities.
Methods: Three hyaluronan hydrogel formulations (HyA-1, HyA-2, HyA-
3) were tested, which differed in their crosslinking chemistry, gelation
time and buffer system. Agarose hydrogel was used as control. hMSCs
(p3) were expanded in DMEM/10%FBS/1% antibiotics. After trypsinization,
cells were suspended in the hydrogel at the desired ﬁnal concentration.
Cell/hydrogel mixture was then aliquoted into 48-well plates and allowed
to crosslink before fresh medium was added. The cell/hydrogel constructs
were cultured up to 14 days. Viability of encapsulated hMSCs was assessed
using a LIVE/DEAD assay. Cell proliferation was determined using Quan-iT
PicoGreen dsDNA assay. All quantitative data were expressed as Mean±SD.
Two-way ANOVA and post-hoc Tukey’s HSD testing were performed using
SYSTAT with P<0.05 considered signiﬁcant.
Results: All HyA hydrogels were able to incorporate hMSCs at a low
(1×106/ml) and a high (10×106/ml) density. Encapsulation of cells did not
